Immunome
IMNM
$10.05
Share price
11.69%
Change (1 day)
-67.46%
Change (1 year)
Categories
Revenue for Immunome (IMNM)
Revenue in 2024 (TTM): A$13.71 Million
According to Immunome's latest financial reports the company's current revenue (TTM 
) is A$14.63 Million. a decrease over the revenue in the year 2023 that were of A$20.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immunome from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$14.53 M | -29.36% |
| 2023 | A$20.57 M | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |